Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2021 | Comprehensive genomic profiling

Umberto Malapelle, PhD, University of Naples Federico II, Naples, Italy, outlines the advantages of comprehensive genomic profiling (a combination of next generation sequencing and liquid biopsy). This technique is effective for detecting a range of mutations and gene alterations at the same time, which allows for faster diagnosis for patients. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.


Speaker’s bureau for Boehringer Ingelheim, AstraZeneca, Roche, MSD, Amgen, Merck, BMS, Thermofisher, Biocartis.

Advisory role for Boehringer Ingelheim, MSD, Amgen, Merck, BMS, Diaceutics, Roche, Eli Lilly, Thermofisher, Janssen.